Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL

Gustave Roussy, Cancer Campus, Grand Paris · 2004
ClinicalTrials.gov · Datasets · License: Public Domain · 2004
Open Source ↗
b-cell-non-hodgkin-lymphomachildrenrelapse
This is a multicentric phase II study of Mabthera (rituximab) in children and adolescents with relapsed and refractory B-cell NHL/L3ALL. The primary objective is to determine the response rate of Rituximab as single agent in relapsed or refractory Burkitt lymphoma, L3 acute leukemia, large B-cell lymphoma and non subclassified aggressive B-cell NHL
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1162030
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive